-
Founded in:
1981-06-17 -
Country:
China -
Address:
No. 16, Saida North 1st Road, Xiqing Economic Development Zone, Tianjin -
Tax NO.:
91120000103069502J -
Registered Funds:
257.942988 yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Diethylstilbestrol |
This product is a synthetic non-steroidal estrogen. Its main effects are: ① Promote the normal development of female organs and secondary sexual characteristics. ② Promote endometrial hyperplasia and vaginal epithelial keratinization. ③ Enhance uterine contraction and increase the sensitivity of the uterus to oxytocin. ④ Small doses stimulate and large doses inhibit the secretion of anterior pituitary gonadotropin and prolactin. ⑤ Anti-androgenic effect.
More
This product is a synthetic non-steroidal estrogen. Its main effects are: ① Promote the normal development of female organs and secondary sexual characteristics. ② Promote endometrial hyperplasia and vaginal epithelial keratinization. ③ Enhance uterine contraction and increase the sensitivity of the uterus to oxytocin. ④ Small doses stimulate and large doses inhibit the secretion of anterior pituitary gonadotropin and prolactin. ⑤ Anti-androgenic effect. |
56-53-1 | 1 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Diethylstilbestrol |
Artificially synthesized non-steroidal estrogen, its effects include: promoting the normal development of female organs and secondary sexual characteristics; promoting endometrial hyperplasia and vaginal epithelial keratinization; enhancing uterine contractions and increasing the sensitivity of the uterus to oxytocin; small doses stimulate while large doses inhibit the secretion of anterior pituitary gonadotropin and prolactin; anti-androgenic effect.
More
Artificially synthesized non-steroidal estrogen, its effects include: promoting the normal development of female organs and secondary sexual characteristics; promoting endometrial hyperplasia and vaginal epithelial keratinization; enhancing uterine contractions and increasing the sensitivity of the uterus to oxytocin; small doses stimulate while large doses inhibit the secretion of anterior pituitary gonadotropin and prolactin; anti-androgenic effect. |
56-53-1 | 1 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Diethylstilbestrol |
This product is a synthetic non-steroidal estrogen. Its main effects are: ① Promote the normal development of female organs and secondary sexual characteristics. ② Promote endometrial hyperplasia and vaginal epithelial keratinization. ③ Enhance uterine contraction and increase the sensitivity of the uterus to oxytocin. ④ Small doses stimulate and large doses inhibit the secretion of anterior pituitary gonadotropin and prolactin. ⑤ Anti-androgenic effect.
More
This product is a synthetic non-steroidal estrogen. Its main effects are: ① Promote the normal development of female organs and secondary sexual characteristics. ② Promote endometrial hyperplasia and vaginal epithelial keratinization. ③ Enhance uterine contraction and increase the sensitivity of the uterus to oxytocin. ④ Small doses stimulate and large doses inhibit the secretion of anterior pituitary gonadotropin and prolactin. ⑤ Anti-androgenic effect. |
56-53-1 | 1 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Propranolol hydrochloride |
1. Non-selective competitive inhibition of adrenaline beta receptor blockers, reducing cardiac contractility and speed, inhibiting vascular smooth muscle contraction, reducing myocardial oxygen consumption, and used to treat angina pectoris; 2. Inhibiting adrenergic excitement of cardiac pacemaker potentials and treating arrhythmias; 3. Inhibiting renin release and reducing cardiac output through central and adrenergic neuron blocking, and used to treat hypertension; 4. Competitively antagonizing the effects of isoproterenol and norepinephrine, reducing plasma renin activity, which may cause bronchospasm, inhibit insulin secretion, and mask hypoglycemia symptoms; 5. Has antiplatelet aggregation effects.
More
1. Non-selective competitive inhibition of adrenaline beta receptor blockers, reducing cardiac contractility and speed, inhibiting vascular smooth muscle contraction, reducing myocardial oxygen consumption, and used to treat angina pectoris; 2. Inhibiting adrenergic excitement of cardiac pacemaker potentials and treating arrhythmias; 3. Inhibiting renin release and reducing cardiac output through central and adrenergic neuron blocking, and used to treat hypertension; 4. Competitively antagonizing the effects of isoproterenol and norepinephrine, reducing plasma renin activity, which may cause bronchospasm, inhibit insulin secretion, and mask hypoglycemia symptoms; 5. Has antiplatelet aggregation effects. |
318-98-9 | 31 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Albuterol sulfate |
Mainly acts on bronchial adrenergic receptors to relax smooth muscles
More
Mainly acts on bronchial adrenergic receptors to relax smooth muscles |
2.4mg | 51022-70-9 | 41 |